General Information

Conference goal and expected outcome

Over the last decade biological therapies have represented a major advancement in the treatment of rheumatic diseases. Despite this progress, however, several problems remain. At the same time, breakthroughs in basic and applied research are yielding a myriad of new potential targets for therapies.
The final conference in the TRiPR series of events - Biological Agents and Emerging Treatments in the Management of Rheumatic Diseases - will address the treatment of both adult and childhood rheumatic diseases with the purpose of reviewing and discussing the progress that has been achieved thus far, the unmet needs that are still faced, and the potential new treatments that the future holds in store. A final session will be devoted to strategies to improve methodologies of translational research on and clinical development in common, as well as rare, forms of rheumatic disorders.

Conference Chair
Alberto Martini (Genoa)

Scientific Committee
Abul K Abbas (San Francisco)
Salvatore Albani (Tucson)
Ornella Della Casa Alberighi (Genoa)
Wietse Kuis (Utrecht)
Tore K. Kvien (Oslo)
Pierre Miossec (Lyon)
Angelo Ravelli (Genoa)
Nicola Ruperto (Genoa)
Costantino Pitzalis (London)

Programme Highlights & Invited Speakers